Tower Research Capital (TRC)’s Wright Medical Group, Inc. Contingent Value Right WMGIZ Stock Holding History

Tower Research Capital (TRC)’s Portfolio WMGIZ Stock Details WMGIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	–	–	4712
2018 Q3	$0	Buy	+100	New	+$136	﹤0.01%	4555
2017 Q2	–	Sell	-3,566	Closed	-$5K	–	3864
2017 Q1	$5K	Buy	3,566 +294	+9%	+$446	﹤0.01%	2257
2016 Q4	$4K	Sell	3,272 -2,300	-41%	-$3.06K	﹤0.01%	3203
2016 Q3	$7K	Sell	5,572 -800	-13%	-$1.08K	﹤0.01%	2382
2016 Q2	$8K	Buy	6,372 +600	+10%	+$803	﹤0.01%	3069
2016 Q1	$7K	Buy	5,772 +91	+2%	+$106	﹤0.01%	2457
2015 Q4	$6K	Buy	+5,681	New	+$5.78K	﹤0.01%	2873

Other funds holding WMGIZ

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Tower Research Capital (TRC)'s WMGIZ Position: Q4 2018 in Review

Tower Research Capital (TRC) sold out of Wright Medical Group, Inc. Contingent Value Right (WMGIZ) in Q4 2018, closing a stake of 100 shares.

Tower Research Capital (TRC) first reported a position in WMGIZ in Q4 2015 and held it in 7 quarters. The position peaked at $8K in Q2 2016. 19 funds tracked by Wall St. Rank hold WMGIZ as of Q4 2018.

Tower Research Capital (TRC) reported no remaining Wright Medical Group, Inc. Contingent Value Right position as of Q4 2018 after selling out during the quarter.
Tower Research Capital (TRC) sold 100 Wright Medical Group, Inc. Contingent Value Right shares in Q4 2018.
Tower Research Capital (TRC) first reported a position in Wright Medical Group, Inc. Contingent Value Right in Q4 2015 and held it in 7 quarters.
Tower Research Capital (TRC)'s Wright Medical Group, Inc. Contingent Value Right position peaked at $8K in Q2 2016.
19 funds tracked by Wall St. Rank held Wright Medical Group, Inc. Contingent Value Right as of Q4 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.